Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up

The Lancet

Volumn 335, Issue 8684, 1990, Pages 270-273

  Clemens, J D ^a,b   Sack, D A ^a,c   Harris, J R ^a,d   van Loon, F ^a   Chakraborty, J ^a   Ahmed, F ^a   Rao, M R ^a,b   Khan, M R ^a   Yunus, Md ^a   Huda, N ^a   Stanton, B F ^a,b   Kay, B A ^a,b   Eeckels, R ^a,f   Walter, S ^e   Svennerholm, A M ^g   Holmgren, J ^g  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; BANGLADESH; CHILD; CHILDHOOD DISEASE; CHOLERA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VACCINATION;

ASIA; BACTERIAL AND FUNGAL DISEASES--PREVENTION AND CONTROL; BANGLADESH; DATA ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; DIARRHEA; DIARRHEA, INFANTILE--PREVENTION AND CONTROL; DISEASES; EVALUATION; EXAMINATIONS AND DIAGNOSES; HEALTH; HEALTH SERVICES; IMMUNIZATION; INFECTIONS; LABORATORY EXAMINATIONS AND DIAGNOSES; PRIMARY HEALTH CARE; RESEARCH METHODOLOGY; SOUTHERN ASIA; VACCINATION;

ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; BANGLADESH; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMAN; INCIDENCE; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TIME FACTORS; VACCINES, INACTIVATED;

EID: 0025157072     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)90080-O     Document Type: Article

References (18)

1. Cholera and the immune response
2. Oral combined B subunit-whole cell cholera vaccine
3. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine
4. Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine
5. Protective efficacy in humans of killed whole- Vibrio oral cholera vaccine with and without the B subunit of cholera toxin
6. Field trial of oral cholera vaccines in Bangladesh
7. Impact of B subunit killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera
8. Endemic cholera in rural Bangladesh, 1966-1980
9. B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity
10. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up
11. Covariance analysis of censored survival data using log linear analysis techniques
12. Review of experience with whole-cell and somatic antigen vaccines
13. Strong biotype and serotype-protective antibacterial and antitoxic immunity in rabbits after cholera infection
14. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial
15. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans